Department of Anaesthesiology and Pain Medicine, Affiliated Hospital of Guangdong Medical University, No. 57 People Avenue South, Zhanjiang, 524001, Guangdong, China.
Department of Thoracic Cardiovascular Surgery, Gaozhou People's Hospital, No. 89 Xiguan Road, Gaozhou, 525200, Guangdong, China.
Sci Rep. 2024 Apr 1;14(1):7620. doi: 10.1038/s41598-024-57834-0.
Radiofrequency ablation (RFA) comparative efficacy of treatments using video-assisted thoracoscopic sympathectomy (VATS) in the long term remains uncertain in patients with palmar hyperhidrosis (PHH). This study aimed to compare the efficacy and safety of RFA and VATS in patients with PHH. We recruited patients aged ≥ 14 years with diagnosed PHH from 14 centres in China. The treatment options of RFA or VATS were assigned to two cohort in patients with PHH. The primary outcome was the efficacy at 1-year. A total of 807 patients were enrolled. After propensity score matching, the rate of complete remission was lower in RFA group than VATS group (95% CI 0.21-0.57; p < 0.001). However, the rates of palmar dryness (95% CI 0.38-0.92; p = 0.020), postoperative pain (95% CI 0.13-0.33; p < 0.001), and surgery-related complications (95% CI 0.19-0.85; p = 0.020) were lower in RFA group than in VATS group, but skin temperature rise was more common in RFA group (95% CI 1.84-3.58; p < 0.001). RFA had a lower success rate than VATS for the complete remission of PHH. However, the symptom burden and cost are lower in patients undergoing RFA compared to those undergoing VATS.Trial Registration: ChiCTR2000039576, URL: http://www.chictr.org.cn/index.aspx .
射频消融 (RFA) 与电视辅助胸腔镜交感神经切断术 (VATS) 治疗手掌多汗症 (PHH) 的长期比较疗效尚不确定。本研究旨在比较 RFA 和 VATS 治疗 PHH 患者的疗效和安全性。我们从中国的 14 个中心招募了年龄≥14 岁的 PHH 患者。将 RFA 或 VATS 的治疗选择分配给 PHH 患者的两个队列。主要结局是 1 年时的疗效。共纳入 807 例患者。经过倾向评分匹配后,RFA 组的完全缓解率低于 VATS 组(95%CI 0.21-0.57;p<0.001)。然而,RFA 组的手掌干燥率(95%CI 0.38-0.92;p=0.020)、术后疼痛率(95%CI 0.13-0.33;p<0.001)和与手术相关的并发症率(95%CI 0.19-0.85;p=0.020)均低于 VATS 组,但 RFA 组的皮肤温度升高更为常见(95%CI 1.84-3.58;p<0.001)。与 VATS 相比,RFA 治疗 PHH 的完全缓解率较低。然而,与 VATS 相比,RFA 组的症状负担和成本较低。试验注册:ChiCTR2000039576,网址:http://www.chictr.org.cn/index.aspx 。